Recent U.S. Food and Drug Administration (FDA) Decision Upsets Careful Balance Struck by Congress in Dietary Supplement Health and Education Act (DSHEA)

Congress struck a careful balance between providing consumers with access to safe dietary supplements and maintaining strict safety and efficacy standards for drugs when it enacted DSHEA in 1994. A recent decision by FDA concerning the regulatory status of nicotinamide mononucleotide (NMN) upsets the careful balance struck by Congress in DSHEA. Because FDA’s abrupt and […]

NPA Celebrates Legal Victory in NMN Case

The NPA hailed the court’s decision to stay the NMN lawsuit as a “monumental victory,” emphasizing that the FDA exceeded its authority and must adhere to the law’s provisions. The ruling allows NMN supplements to remain on the market while the FDA reviews the citizen petition.

FDA Declares NMN Not a Legal Dietary Ingredient

The FDA announced that β-nicotinamide mononucleotide (β-NMN) is not a legal dietary ingredient, citing its prior investigation as a drug. The Council for Responsible Nutrition (CRN) responded, expressing concern that this decision stifles innovation and disregards consumer interests.